Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans

AUTOR(ES)

Routh, Madhushree M, Chauhan, Nitin M, Karuppayil, S Mohan

FONTE

Braz. J. Microbiol.

DATA DE PUBLICAÇÃO

2013-09

RESUMO

Candida infections are very common in cancer patients and it is a common practice to prescribe antifungal antibiotics along with anticancer drugs. Yeast to hyphal form switching is considered to be important in invasive candidiasis. Targeting morphogenetic switching may be useful against invasive candidiasis. In this study, we report the antimorphogenetic properties of thirty cancer drugs.

Documentos Relacionados

• The Golgi GDPase of the Fungal Pathogen Candida albicans Affects Morphogenesis, Glycosylation, and Cell Wall Properties
• Morphogenesis, Adhesive Properties, and Antifungal Resistance Depend on the Pmt6 Protein Mannosyltransferase in the Fungal Pathogen Candida albicans
• Migration of the fungal pathogen Candida albicans across endothelial monolayers.
• Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans.
• The TATA-Binding Protein (TBP) from the Human Fungal Pathogen Candida albicans Can Complement Defects in Human and Yeast TBPs